Cyclo Therapeutics Inc.

0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM
0.72
0.00%
After-hours: Mar 25, 2025, 04:00 PM EDT

Cyclo Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00
Revenue 1.08M 1.38M 1.59M 903.38K 1.01M 1.01M 1.24M 1.5M 950.46K 1.57M 1.69M 1.04M 1.03M 802.37K 623.87K 494.94K 751.18K 542.31K 454.36K 464.69K 394.53K 522.37K 289.43K 384.59K
Cost of Revenue 98.46K 138.93K 156.08K 66.4K 75.49K 105.03K 132.92K 198.43K 124.42K 272.64K 426.02K 139.68K 273.76K 114.66K 110.83K 99.32K 118.4K 125.19K 66.66K 78.83K 45.43K 84.48K 34.03K 99.22K
Gross Profit 977.95K 1.24M 1.43M 836.98K 931.71K 906.45K 1.1M 1.3M 826.03K 1.29M 1.27M 905.26K 758.09K 687.71K 513.04K 395.62K 632.77K 417.13K 387.7K 385.87K 349.1K 437.89K 255.4K 285.37K
Operating Income -20.05M -15.61M -14.27M -8.96M -7.39M -4.27M -3.84M -4.21M -2.41M -562.31K 336.64K 157.49K -74.26K -11.87K -200.94K -239.47K 193.67K -45.9K -112.61K -278.91K 85.6K 197.35K -23.71K -289.84K
Interest Income n/a 12.47K 3.4K 19.8K 12.03K n/a n/a n/a n/a n/a n/a 3.51K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -20.06M -15.45M -14.29M -8.94M -7.53M -4.26M -3.83M -4.22M -2.43M -592.69K 284.91K 99.2K -97.77K -12.53K -193.13K -213.23K 203.55K -101.83K 52.54K -561.49K 69.98K 165.58K -56.54K -315.83K
Net Income -20.06M -15.28M -14.31M -8.92M -7.67M -4.26M -3.83M -4.22M -2.55M -592.69K 204.91K 74.2K -97.77K -37.53K -193.13K -413.23K 653.55K -101.83K -172.46K -561.49K 294.98K 165.58K -113.88K -510.83K
Selling & General & Admin 6.83M 7.82M 6.52M 3.68M 3.44M 2.44M 2.63M 2.65M 2.23M 1.55M 648.45K 570.98K 799.6K 678.64K 693.33K 520.06K 439.1K 350.68K 500.32K 664.78K 263.5K 240.54K 279.11K 548.79K
Research & Development 14.18M 9M 9.15M 6.1M 4.87M 2.71M 2.29M 1.86M 658.5K 94.13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses n/a 30.5K 27.54K 19.95K 13.98K 13.95K 19.77K 130.95K 202.01K 217.52K 188.76K 159.93K 32.75K 20.94K 20.65K 22.87K 439.1K 350.68K 500.32K 664.78K 263.5K 240.54K 279.11K 575.21K
Operating Expenses 21.04M 16.85M 15.7M 9.8M 8.32M 5.16M 4.95M 4.65M 3.09M 1.86M 837.21K 730.91K 832.35K 699.58K 713.98K 542.93K 439.1K 350.68K 500.32K 664.78K 263.5K 240.54K 279.11K 575.21K
Interest Expense n/a n/a n/a n/a n/a n/a n/a 28.6K 31.29K 33.67K 53.87K 61.8K 25.81K 4.3K n/a 1.82K 10.75K 11.05K 13.96K 12.03K 22.6K 30.92K 35.44K 28.29K
Selling & Marketing Expenses 3.9K 13.06K 18.34K 5.01K 5.88K 5.64K 7.85K 7.16K 7.57K 10.9K 8.91K 10.81K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 21.13M 16.99M 15.85M 9.86M 8.4M 5.27M 5.08M 4.85M 3.22M 2.13M 1.26M 870.59K 1.11M 814.24K 824.81K 642.25K 557.51K 475.86K 566.97K 743.61K 308.93K 325.02K 313.14K 674.43K
Income Tax n/a -171K 18.52K -18.53K 141.75K 11.77K n/a 28.6K 120K 33.67K 80K 25K 25.81K 25K n/a 200K -450K 168.28K 225K 282.58K -225K 31.77K 90.17K 195K
Shares Outstanding (Basic) 16.33M 8.44M 6.37M 1.6M 1.08M 817.57K 720.37K 633.54K 562.09K 505.43K 371.66K 366.8K 358.07K 337.11K 287.5K 235.33K 179.2K 148.15K 120.18K 72.32K 50.05K 47.91K 43.89K 37.02K
Shares Outstanding (Diluted) 16.33M 8.44M 6.37M 1.6M 1.08M 817.57K 720.37K 633.54K 562.09K 505.43K 371.66K 366.8K 358.07K 337.11K 287.5K 235.33K 179.2K 148.15K 120.18K 72.32K 50.05K 47.91K 43.89K 37.02K
EPS (Basic) -1.23 -1.81 -2.25 -5.58 -7.09 -5.2 -5.32 -6.67 -4.54 -1.17 1.00 1.00 -0.27 -0.11 -0.67 -1.76 3.60 -0.69 -1.44 -7.76 5.00 3.00 -2.59 -13.8
EPS (Diluted) -1.23 -1.81 -2.25 -5.58 -7.09 -5.2 -5.32 -6.67 -4.54 -1.17 1.00 1.00 -0.27 -0.11 -0.67 -1.76 3.60 -0.69 -1.44 -7.76 5.00 3.00 -2.59 -13.8
EBITDA -20.03M -15.6M -14.27M -8.95M -7.39M -4.24M -3.82M -4.09M -2.23M -406.57K 486.81K 303.64K -39.21K 12.72K -172.55K -188.55K 218.04K -63.32K -77.6K -251.15K 90.92K 221.54K 27.58K -66.02K
Depreciation & Amortization 19.28K 19.48K 16.83K 12.76K 5.68K 10.12K 9.27K 107.1K 169.03K 152.45K 148.04K 142.64K 32.75K 20.94K 20.58K 22.87K 24.37K 27.46K 35.01K 27.76K 37.81K 24.19K 51.29K 26.41K